Skip to content
DataLookout
Menu

NCT05213676

De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia

StatusRecruiting
PhasePhase 4
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 4 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Enrollment increased: 600 → 900 participants Show 4 more changesShow less
    • Eligibility criteria expanded, about 8 words
    • Primary endpoints: details revised at 1 of 1 entry
    • Site details revised at 18 of 19 sites
    • Collaborators: details revised at 16 of 18 entries
  2. Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 8 more changesShow less
    • Primary completion date: Dec 31, 2029 to Oct 31, 2030
    • Start date changed from estimate of Jan 1, 2025 to Nov 1, 2025
    • Primary endpoint revised
    • Study sites: 1 to 19
    • Study completion date: Dec 31, 2030 to Apr 30, 2031
    • Secondary endpoints revised (5)
    • Collaborators expanded, about 113 words
    • Study title shortened, about 16 words
  3. Notable Primary completion date: Jan 30, 2028 to Dec 31, 2029
    • Start date: Jan 1, 2023 to Jan 1, 2025
    • Study completion date: Jan 30, 2028 to Dec 31, 2030
    v2
  4. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Number of participants who require Extracorporeal Life Support (ECLS) and/or who die prior to discharge
Timeframe: from birth through hospital discharge (up to 12 months from birth)

Secondary (4)

Number of participants who require Extracorporeal Life Support (ECLS) prior to discharge
Number of participants who die prior to discharge
Change in oxygenation
Total cost of initial inpatient care from birth through hospital discharge, per center

Arms and interventions

Inhaled Nitric Oxide (iNO) useActive comparator

The center will use iNO per their usual protocol in the initial resuscitation period (defined as birth through stabilization and CDH repair). No center will alter any component of their standard clinical practice guideline or protocol governing CDH care.

De-implementation of Inhaled Nitric Oxide (iNO) useActive comparator

The center will stop using iNO in the initial resuscitation period (defined as birth through stabilization and CDH repair).

Drugs: Inhaled Nitric Oxide (iNO) use

Other: De-implementation of Inhaled Nitric Oxide (iNO) use

Sites

19 sites in 1 country